CMNV causes POH-VAU in humans and mice. The disease is characterized by recurring episodes of
anterior uveitis presenting with extreme ocular hypertension, precipitates and aqueous cells. Repeated episodes lead to persistent intraocular pressure elevation that does not respond to medical intervention, "irreversible optic nerve damage, corneal endothelium loss, iris atrophy and severe vision impairment. Most patients are home-based aquatic animal handlers, consumers with aquatic products, or people who come into contact with raw or live aquatic animals without eye protection in other ways. The remaining cases are close contacts of high-risk groups or those living near aquaculture environments. Infection can happen in mice by injection and by sharing water bottles with an infected mouse. It is possible that contacts of high-risk groups acquired this virus through a similar mechanism (e.g. shared utensils). Current (2026) treatment consists of
ganciclovir applied to the eye, steroids applied to the eye, and IOP-lowering medications. This combination is effective in 70% of patients, though half of them required long-term medication. The remaining 30% eventually require antiglaucoma surgery. If IOP elevation is persistent,
trabeculectomy may be done. == In crustaceans ==